Transgene Market Cap

Transgene has a market cap or net worth of €250.83 million as of December 5, 2025. Its market cap has increased by 148.09% in one year.

Market Cap

250.83M

Enterprise Value

265.12M

Revenue

7.58M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.92

Market Cap Chart

Since March 30, 1998, Transgene's market cap has increased from 151.86M to 250.83M, an increase of 65.17%. That is a compound annual growth rate of 1.83%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	250.83M	179.46%
Dec 31, 2024	89.75M	-34.86%
Dec 29, 2023	137.78M	-16.38%
Dec 30, 2022	164.76M	-33.52%
Dec 31, 2021	247.84M	79.73%
Dec 31, 2020	137.90M	6.95%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
EssilorLuxottica Société anonyme	141.76B
Sanofi	104.83B
Sartorius Stedim Biotech	20.94B
bioMérieux	12.72B
Eurofins Scientific SE	10.52B
Ipsen	10.15B
ABIVAX Société Anonyme	7.68B
Virbac	2.99B

Market Cap Rankings